Insight Molecular Diagnostics (IMDX) Operating Income Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Operating Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 48.29% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 31.33% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 33.00% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 0.00% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.08% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 14.49% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 17.41% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 14.47% |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -15.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.85% |
| Mar 31, 2026 | -33.62% |
| Dec 31, 2025 | 30.31% |
| Sep 30, 2025 | 18.25% |
| Jun 30, 2025 | -98.79% |
| Mar 31, 2025 | 26.63% |
| Dec 31, 2024 | -107.84% |
| Sep 30, 2024 | -107.51% |
| Jun 30, 2024 | 40.31% |
| Mar 31, 2024 | -258.41% |
| Dec 31, 2023 | -38.90% |
| Sep 30, 2023 | -281.77% |
| Jun 30, 2023 | -410.09% |
| Mar 31, 2023 | 293.90% |
| Dec 31, 2022 | 67.35% |
| Sep 30, 2022 | 87.46% |
| Jun 30, 2022 | 88.02% |
| Mar 31, 2022 | 73.44% |
| Dec 31, 2021 | -469.33% |
| Sep 30, 2021 | -117.87% |